MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
3114.87%
Quick Ratio
3114.87%
Cash Ratio
1056.62%
Debt to Asset Ratio
129.68%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
169,873 396,486 160,462 190,574
Restricted cash equivalents
NaN NaN NaN 2,413
Marketable securities
321,652 58,722 10,000 9,991
Prepaid expenses
6,394 1,152 747 1,500
Other current assets
2,859 1,745 1,277 449
Total current assets
500,778 458,105 172,486 204,927
Restricted cash
168 168 168 0
Property and equipment, net
565 533 271 0
Operating lease right-of-use assets
2,827 2,936 3,043 24
Other assets
2,408 2,384 269 420
Total assets
506,746 464,126 176,237 205,371
Accounts payable
1,043 5,127 885 669
Accrued liabilities
14,727 19,764 17,702 58,104
Operating lease liabilities
307 280 252 0
Total current liabilities
16,077 25,171 18,839 58,773
Operating lease liabilities, less current portion
2,632 2,720 2,807 0
Warrant liabilities
638,461 600,547 2,380,078 1,652,298
Total liabilities
657,170 628,438 2,401,724 1,711,071
Common stock, 0.0001 par value 800,000,000 and 400,000,000 shares authorized as of march 31, 2026 and december 31, 2025, respectively 54,185,582and 38,720,196 shares issued and outstanding as of march 31, 2025 and december 31, 2025, respectively
19 18 15 13
Additional paid-in capital
1,222,823 988,604 650,319 557,422
Accumulated other comprehensive (loss) income
-706 41 12 14
Accumulated deficit
-1,372,560 -1,152,975 -2,875,833 -2,063,149
Total stockholders' deficit
-150,424 -164,312 -2,225,487 -1,505,700
Total liabilities and stockholders' equity (deficit)
506,746 464,126 176,237 205,371
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$321,652K Cash and cashequivalents$169,873K Prepaid expenses$6,394K Other current assets$2,859K Total current assets$500,778K Operating leaseright-of-use assets$2,827K Other assets$2,408K Property and equipment,net$565K Restricted cash$168K Total assets$506,746K Accumulated deficit-$1,372,560K Accumulated othercomprehensive (loss) income-$706K Total liabilities andstockholders' equity...$506,746K Total stockholders'deficit-$150,424K Additional paid-in capital$1,222,823K Common stock, 0.0001par value...$19K Total liabilities$657,170K Warrant liabilities$638,461K Total currentliabilities$16,077K Operating leaseliabilities, less current...$2,632K Accrued liabilities$14,727K Accounts payable$1,043K Operating leaseliabilities$307K

Vor Biopharma Inc. (VOR)

Vor Biopharma Inc. (VOR)